Changchun high tech industry (Group) Co., Ltd. (000661)

Changchun high tech industry (Group) Co., Ltd. (000661)

In June 1993, Changchun high tech industry (Group) Co., Ltd. was established exclusively by Changchun high tech Industry Development Corporation, with a total share capital of 137.5 million shares.

On December 18, 1996, the company's stock was listed on Shenzhen Stock Exchange, which is one of the earliest listed companies in Northeast China.

Over the past 20 years since its listing, Changchun hi tech has successfully transformed from a company focusing on the infrastructure construction of hi tech Zone at the beginning of its establishment to an enterprise group focusing on the field of pharmaceutical science and technology innovation and implementing industrial investment. Adhering to the corporate culture of "innovation, concentration, inclusiveness, sharing and development", the company has practiced the core values of creating value for customers, creating opportunities for employees, creating benefits for shareholders and taking responsibility for the society. It has clearly defined the industrial positioning of biopharmaceuticals as the main and real estate as the auxiliary, and formed three industrial development platforms of genetic engineering drugs, biological vaccines and modern Chinese medicine, It has achieved the "four carriages" development pattern of Jinsai pharmaceutical, Baike biological, Huakang pharmaceutical and high tech real estate, and created a good situation of shared development and win-win cooperation.

The company's business performance continued to grow, ranking 73 and 56 in the top 100 of the national pharmaceutical industry in 2017 and 2018 respectively.

>> tungsten carbide rings silver